Type
1.
Das CK, Mahapatra A, Das MM, Sahoo D, Chayani N. Coexistence of cutaneous tuberculosis (scrofuloderma) and hanseniasis-a rare presentation. Journal of clinical and diagnostic research : JCDR [Internet]. 2014;8(2):141-2. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972534/pdf/jcdr-8-141.pdf
Type
1.
Thakkar S, Patel S. Clinical profile of leprosy patients: a prospective study. Indian journal of dermatology [Internet]. 2014;59(2):158-62. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969675/
Type
1.
Moreira SC, Batos CJC, Tawil L. Epidemiological situation of leprosy in Salvador from 2001 to 2009. Anais brasileiros de dermatologia [Internet]. 2014;89(1):107-17. Available from: http://www.scielo.br/pdf/abd/v89n1/0365-0596-abd-89-01-0107.pdf
Type
1.
Chopra R, Kalaiarasan P, Ali S, Srivastava A, Aggarwal S, Garg V, et al. PARK2 and proinflammatory/anti-inflammatory cytokine gene interactions contribute to the susceptibility to leprosy: a case-control study of North Indian population. BMJ open [Internet]. 2014;4(2):e004239. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939656/pdf/bmjopen-2013-004239.pdf
Type
1.
Rubini M, Zaio P, Roberts C. Tuberculosis and leprosy in Italy: new skeletal evidence. Homo : internationale Zeitschrift fur die vergleichende Forschung am Menschen. 2014;65(1):13-32.
Type
1.
Anjayani S, Wirohadidjojo YW, Adam AM, Suwandi D, Seweng A, Amiruddin MD. Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. International journal of dermatology. 2014;53(1):109-13.
Type
1.
Prapanna P, Srivastava R, Arora VK, Singh N, Bhatia A, Kaur I. Immunocytochemical detection of mycobacterial antigen in extrapulmonary tuberculosis. Diagnostic cytopathology. 2014;42(5):391-5.
Type
1.
Chaitanya, Jadhav, Lavania, Singh, Valluri, Sengupta. Interleukin-17F single-nucleotide polymorphism (7488T>C) and its association with susceptibility to leprosy. International journal of immunogenetics. 2014;41(2):131-7.
Type
1.
Kumar S, Naqvi RA, Ali R, Rani R, Khanna N, Rao. FoxP3 provides competitive fitness to CD4⁺CD25⁺ T cells in leprosy patients via transcriptional regulation. European journal of immunology. 2014;44(2):431-9.
Type
1.
Ramos J, Reyes F, Lemma D, Tesfamariam A, Belinchón I, Górgolas M. The burden of leprosy in children and adolescents in rural southern Ethiopia. Paediatrics and international child health. 2014;34(1):24-8.